Prevident Orthodefense

Sodium Fluoride


Colgate Oral Pharmaceuticals, Inc.
Human Prescription Drug
NDC 0126-0289
Prevident Orthodefense also known as Sodium Fluoride is a human prescription drug labeled by 'Colgate Oral Pharmaceuticals, Inc.'. National Drug Code (NDC) number for Prevident Orthodefense is 0126-0289. This drug is available in dosage form of Paste, Dentifrice. The names of the active, medicinal ingredients in Prevident Orthodefense drug includes Sodium Fluoride - 6 mg/mL . The currest status of Prevident Orthodefense drug is Active.

Drug Information:

Drug NDC: 0126-0289
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Prevident Orthodefense
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Prescription Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Sodium Fluoride
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Colgate Oral Pharmaceuticals, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Paste, Dentifrice
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:SODIUM FLUORIDE - 6 mg/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:DENTAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED DRUG OTHER
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 04 Mar, 2019
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 28 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Colgate Oral Pharmaceuticals, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:392038
630194
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0301260289922
UPC stands for Universal Product Code.
UNII:8ZYQ1474W7
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
0126-0289-92100 mL in 1 BOTTLE (0126-0289-92)07 Mar, 2019N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Product Elements:

Prevident orthodefense sodium fluoride sodium fluoride fluoride ion fd&c blue no. 1 carboxymethylcellulose sodium, unspecified fumaric acid hydrated silica mica poloxamer 338 polyethylene glycol 600 sodium benzoate sodium lauryl sulfate saccharin sodium sorbitol titanium dioxide tricalcium phosphate water xanthan gum

Indications and Usage:

Indications and usage a dental caries preventive; for twice daily self-applied topical use. prevident® 5000 ortho defense™ 1.1% sodium fluoride toothpaste in a squeeze bottle is easily applied onto a toothbrush. this prescription toothpaste should be used twice daily in place of your regular toothpaste unless otherwise instructed by your dental professional. may be used in areas where drinking water is fluoridated since topical fluoride cannot produce fluorosis. (see warnings for exception.)

Warnings:

Warnings prolonged daily ingestion may result in various degrees of dental fluorosis in pediatric patients under age 6 years, especially if the water fluoridation exceeds 0.6 ppm, since younger pediatric patients frequently cannot perform the brushing process without significant swallowing. use in pediatric patients under age 6 years requires special supervision to prevent repeated swallowing of toothpaste which could cause dental fluorosis. pediatric patients under age 12 should be supervised in the use of this product. read directions carefully before using. keep out of reach of infants and children.

General Precautions:

General not for systemic treatment. do not swallow.

Dosage and Administration:

Dosage and administration follow these instructions unless otherwise instructed by your dental professional: 1. adults and pediatric patients 6 years of age or older, apply a thin ribbon of prevident® 5000 ortho defense™ to a toothbrush. brush teeth thoroughly twice daily for two minutes in place of your regular toothpaste. 2. after use, adults expectorate. for best results, do not eat, drink, or rinse for 30 minutes. pediatric patients, age 6-16, expectorate after use and rinse mouth thoroughly.

Contraindications:

Contraindications do not use in pediatric patients under age 6 years unless recommended by a dentist or physician.

Adverse Reactions:

Adverse reactions allergic reactions and other idiosyncrasies have been rarely reported.

Use in Pregnancy:

Pregnancy teratogenic effects pregnancy category b it has been shown that fluoride crosses the placenta of rats, but only 0.01% of the amount administered is incorporated in fetal tissue. animal studies (rats, mice, rabbits) have shown that fluoride is not a teratogen. maternal exposure to 12.2 mg fluoride/kg of body weight (rats) or 13.1 mg/kg of body weight (rabbits) did not affect the litter size or fetal weight and did not increase the frequency of skeletal or visceral malformations. there are no adequate and well-controlled studies in pregnant women. however, epidemiological studies conducted in areas with high levels of naturally fluoridated water showed no increase in birth defects. heavy exposure to fluoride during in utero development may result in skeletal fluorosis which becomes evident in childhood.

Pediatric Use:

Pediatric use the use of prevident® 5000 ortho defense™ in pediatric age groups 6 to 16 years as a caries preventive is supported by pioneering clinical studies with 1.1% sodium fluoride gels in mouth trays in students age 11 to 14 years conducted by englander et al. 2-4 safety and effectiveness in pediatric patients below the age of 6 years have not been established. please refer to the contraindications and warnings sections.

Geriatric Use:

Geriatric use of the total number of subjects in clinical studies of 1.1 % (w/v) sodium fluoride, 15 percent were 65 and over, while 1 percent were 75 and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. this drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. 5

Overdosage:

Overdosage accidental ingestion of large amounts of fluoride may result in acute burning in the mouth and sore tongue. nausea, vomiting, and diarrhea may occur soon after ingestion (within 30 minutes) and are accompanied by salivation, hematemesis, and epigastric cramping abdominal pain. these symptoms may persist for 24 hours. if less than 5 mg fluoride/kg body weight (i.e., less than 2.3 mg fluoride/lb body weight) has been ingested, give calcium (e.g., milk) orally to relieve gastrointestinal symptoms and observe for a few hours. if more than 5 mg fluoride/kg body weight (i.e., more than 2.3 mg fluoride/lb body weight) has been ingested, induce vomiting, give orally soluble calcium (e.g., milk, 5% calcium gluconate or calcium lactate solution) and immediately seek medical assistance. for accidental ingestion of more than 15 mg fluoride/kg of body weight (i.e., more than 6.9 mg fluoride/lb body weight), induce vomiting and admit immediately to a hospital facility. a treatment dose (a thin ribbon) of prevident® 5000 ortho defense™ contains approximately 2.5 mg fluoride. a 3.4 fl oz (100 ml) bottle contains approximately 605 mg fluoride.

Description:

Description self-topical neutral fluoride dentifrice containing 1.1% (w/w) sodium fluoride for use as a dental caries preventive in adults and pediatric patients. active ingredient sodium fluoride 1.1% (w/w) inactive ingredients blue 1, cellulose gum, flavor, fumaric acid, hydrated silica, mica, poloxamer 338, peg-12, sodium benzoate, sodium lauryl sulfate, sodium saccharin, sorbitol, titanium dioxide, tricalcium phosphate, water, xanthan gum

Clinical Pharmacology:

Clinical pharmacology frequent topical applications to the teeth with preparations having a relatively high fluoride content increase tooth resistance to acid dissolution and enhance penetration of the fluoride ion into tooth enamel.

Carcinogenesis and Mutagenesis and Impairment of Fertility:

Carcinogenesis, mutagenesis, impairment of fertility in a study conducted in rodents, no carcinogenesis was found in male and female mice and female rats treated with fluoride at dose levels ranging from 4.1 to 9.1 mg/kg of body weight. equivocal evidence of carcinogenesis was reported in male rats treated with 2.5 and 4.1 mg/kg of body weight. in a second study, no carcinogenesis was observed in rats, males or females, treated with fluoride up to 11.3 mg/kg of body weight. epidemiological data provide no credible evidence for an association between fluoride, either naturally occurring or added to drinking water, and risk of human cancer. fluoride ion is not mutagenic in standard bacterial systems. it has been shown that fluoride ion has potential to induce chromosome aberrations in cultured human and rodent cells at doses much higher than those to which humans are exposed. in vivo data are conflicting. some studies report chromosome damage in rodents, while other studies using similar
protocols report negative results. potential adverse reproductive effects of fluoride exposure in humans have not been adequately evaluated. adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. other studies conducted in rats demonstrated that lower concentrations of fluoride (5 mg/kg of body weight) did not result in impaired fertility and reproductive capabilities.

How Supplied:

How supplied 3.4 fl oz (100ml) in plastic bottles. mild mint: ndc 0126-0289-92 storage store at controlled room temperature, 68-77°f (20-25°c)

Package Label Principal Display Panel:

Principal display panel - 100 ml bottle label ndc 0126-0289-92 p9931143 colgate ® prevident ® 5000 ppm rx only ortho defense 1.1% sodium fluoride for orthodontic patients prescription strength toothpaste contains tri-calcium phosphate mild mint 3.4 fl oz (100 ml) principal display panel - 100 ml bottle label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.